Med Prep Compounded Products Recalled Due to Mold Contamination
Med Prep Consulting Inc., is recalling all products compounded at its facility due to a lack of sterile conditions. The recall was issued after a Connecticut hospital that received 50ml bags of MAGNESIUM SULFATE 2GM IN DEXTROSE 5% IN WATER intravenous solution confirmed the presence of mold in the solution. In addition to the magnesium sulfate product, Med Prep also produces other compounds such as antibiotics, antiemetics, labor and delivery drugs, cardiac medications, pain management drugs, sedatives, and general anesthetics.
Med Prep is a specialty intravenous (IV) pharmacy licensed in the state of New Jersey. It provides compounded medications to regional hospital pharmacies and related departments as well as physician’s offices.
A total of five contaminated bags of MAGNESIUM SULFATE 2GM IN DEXTROSE 5% IN WATER were discovered which prompted the recall. At this time, no injuries or illnesses have been reported in conjunction with this recall. However, it has been noted that administration of this contaminated IV product could result in a fatal infection in a broad array of patients.
Last year, the New England Compounding Center (NECC), a compounding pharmacy, supplied contaminated steroid injections to hospitals and outpatient clinics across the U.S. resulting in a serious outbreak of fungal meningitis. To this date, over 50 people have died and hundreds have been sickened from these injections.
